Solid Phase Extraction (SPE)
Fatty liver disease 'does not increase risk of death'
Nov 25 2011
Non-alcoholic fatty liver disease (NAFLD) does not affect the long-term survival of sufferers, as previously thought, according to new research.
Scientists at John Hopkins School of Medicine successfully used solid phase extraction data to assess enzyme and substrate levels associated with NAFLD in over 11,000 patients.
The findings, published in the British Medical Journal, show no increase in mortality among those diagnosed with NAFLD, which was identified in around 20 per cent of the participants.
Study leader Mariana Lazo explained that the data did not show NAFLD to be a risk factor for cardiovascular disease.
"We were surprised to say the least because we expected to learn by how much non-alcoholic fatty liver disease increased the risk of death and instead found the answer was not at all," she added.
However, Ms Lazo indicated further research would be needed to determine if advanced variations of the condition pose more serious consequences.
Posted by Fiona Griffiths
Chromatography Today - Buyers' Guide 2022
In This Edition Modern & Practocal Applications - Accelerating ADC Development with Mass Spectrometry - Implementing High-Resolution Ion Mobility into Peptide Mapping Workflows Chromatogr...
View all digital editions
Plastics Recycling World Expo Europe
Jun 14 2023 Essen, Germany
Jun 18 2023 Dusseldorf, Germany
Jul 04 2023 Cardiff, UK
Jul 11 2023 Lagos, Nigeria
ACS National Meeting & Expo, Fall 2023
Aug 13 2023 San Francisco, CA, USA